{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:32:28Z","timestamp":1772227948297,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2000,11,1]]},"DOI":"10.2174\/1381612003398753","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T20:10:31Z","timestamp":1111695031000},"page":"1725-1736","source":"Crossref","is-referenced-by-count":17,"title":["Clinical Experience with Specific COX-2 Inhibitors in Arthritis"],"prefix":"10.2174","volume":"6","author":[{"given":"Leslie","family":"Crofford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/65567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T09:43:14Z","timestamp":1448012594000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=6&issue=17&spage=1725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,1]]},"references-count":0,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2000,11,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612003398753","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11,1]]}}}